Personal information

Verified email domains

immunology, cell signalling, PI3K
United Kingdom

Biography

Professor of Immunology, Department of Pathology, University of Cambridge.

Activities

Employment (3)

University of Cambridge: Cambridge, Cambridgeshire, GB

2017 to present | Professor of Immunology (Department of Pathology)
Employment
Source: Self-asserted source
Klaus Okkenhaug

Babraham Institute: Cambridge, Cambridgeshire, GB

2003 to 2017 | Group Leader (Laboratory of Lymphocyte Signalling and Development)
Employment
Source: Self-asserted source
Klaus Okkenhaug

Ludwig Institute for Cancer Research: London, GB

1999 to 2002 | Postdoc (Cell signalling)
Employment
Source: Self-asserted source
Klaus Okkenhaug

Education and qualifications (2)

University of Toronto: Toronto, Ontario, CA

1994 to 1998 | PhD (Immunology)
Education
Source: Self-asserted source
Klaus Okkenhaug

University of Victoria : Victoria, British Columbia, CA

1989 to 1993 | BSc (Biochemistry)
Education
Source: Self-asserted source
Klaus Okkenhaug

Funding (12)

Enhancing T cell immunity to cancer metastasis

2024-03-31 to 2029-03-30 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/Y013301/1
Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

Novel mechanisms of regulatory T cell mediated suppression: a fundamental role for VPS34

2020-02-01 to 2023-01-31 | Grant
Biotechnology and Biological Sciences Research Council (Swindon, GB)
GRANT_NUMBER: BB/T007826/1
Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

Orchestration of PI3K-dependent transcriptional programmes by the transcription factor BACH2

2016-03-31 to 2019-06-14 | Grant
Biotechnology and Biological Sciences Research Council (Swindon, GB)
GRANT_NUMBER: BB/N007794/1
Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

MICA: Fundamental Role of Phosphoinositide 3-kinase delta in Infection and Immunity: Insights from a Novel Primary Immune Deficiency Syndrome, APDS

2015-09-13 to 2020-12-13 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/M012328/2
Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

MICA: Fundamental Role of Phosphoinositide 3-kinase delta in Infection and Immunity: Insights from a Novel Primary Immune Deficiency Syndrome, APDS

2015-02-01 to 2015-06-13 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/M012328/1
Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

Elucidating the differential and complementary roles of P13K insoforms P110 and p110 in lymphocytes

2014-09-30 to 2018-09-29 | Grant
Biotechnology and Biological Sciences Research Council (Swindon, GB)
GRANT_NUMBER: BB/M503332/1
Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

PI3K signalling in Immunity and Infection.

2011-09-01 to 2018-03-31 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

095691/Z/11/Z

Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

Modulation of immune responses during haematopoietic cell transplantation.

2010-02-01 to 2013-05-31 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

088621/B/09/Z

Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

BBSRC Industrial CASE Partnership Grant

2009-09-30 to 2013-09-29 | Grant
Biotechnology and Biological Sciences Research Council (Swindon, GB)
GRANT_NUMBER: BB/H531094/1
Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

PI3K signalling at the immune synapse asymmetric division and immunological memory.

2008-02-01 to 2011-07-30 | Grant
Biotechnology and Biological Sciences Research Council (Swindon, GB)
GRANT_NUMBER: BB/F015461/1
Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

PI3K signalling in regulatory T cells.

2007-01-26 to 2010-01-25 | Grant
Biotechnology and Biological Sciences Research Council (Swindon, GB)
GRANT_NUMBER: BB/E009867/1
Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

Role of CD28 and the PI3K p110delta in islet transplantation

2006-04-01 to 2007-01-31 | Grant
Breakthrough T1D (New York, US)
GRANT_NUMBER:

5-2006-229

Source: Self-asserted source
Klaus Okkenhaug via DimensionsWizard

Peer review (47 reviews for 13 publications/grants)

Review activity for American Association for the Advancement of Science (3)
Review activity for American Association of Immunologists (4)
Review activity for British journal of cancer. (1)
Review activity for Cell Press (6)
Review activity for Frontiers (3)
Review activity for Impact Journals (1)
Review activity for National Academy of Sciences (4)
Review activity for Nature communications (3)
Review activity for Nature immunology. (2)
Review activity for Nature Publishing Group (7)
Review activity for Portland Press Ltd. (3)
Review activity for Public Library of Science (5)
Review activity for Wiley (5)